Hybridoma & B-Cell Sequencing
Unleash The Potential of Recombinant Antibody Technology
Services Overview
Whether creating novel antibodies or protecting existing antibodies, the first step is sequencing B-Cells or hybridomas. Novel antibodies can be generated after B-cells are isolated from immunized animals or humans. By sequencing your hybridoma cell line, we provide a robust safeguard against potential loss of this invaluable resource. These genetic blueprints enable the precise and reliable recombinant production of your antibodies, ensuring an uninterrupted and consistent supply.
Key Benefits
How it Works
